HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alexandre Harlé Selected Research

Neoplasms (Cancer)

1/2024Tumor-derived cell-free DNA and circulating tumor cells: partners or rivals in metastasis formation?
11/2023Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical Trial.
10/2023ESR1 Gene Mutations and Liquid Biopsy in ER-Positive Breast Cancers: A Small Step Forward, a Giant Leap for Personalization of Endocrine Therapy?
6/2023Personalized follow-up of circulating DNA in resected stage III/IV melanoma: PERCIMEL multicentric prospective study protocol.
10/2022Development of a Clinical-Biological Model to Assess Tumor Progression in Metastatic Pancreatic Cancer: Post Hoc Analysis of the PRODIGE4/ACCORD11 Trial.
3/2022Intraoperative prediction of non-sentinel lymph node metastases in breast cancer using cytokeratin 19 mRNA copy number: A retrospective analysis.
1/2022DDB2 represses epithelial-to-mesenchymal transition and sensitizes pancreatic ductal adenocarcinoma cells to chemotherapy.
10/2021A NGS-based Blood Test For the Diagnosis of Invasive HPV-associated Carcinomas with Extensive Viral Genomic Characterization.
10/2020Evaluation of 3 molecular-based assays for microsatellite instability detection in formalin-fixed tissues of patients with endometrial and colorectal cancers.
1/2020Pathology of HPV-Associated Head and Neck Carcinomas: Recent Data and Perspectives for the Development of Specific Tumor Markers.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alexandre Harlé Research Topics

Disease

26Neoplasms (Cancer)
01/2024 - 02/2013
10Breast Neoplasms (Breast Cancer)
10/2023 - 03/2013
8Colorectal Neoplasms (Colorectal Cancer)
10/2020 - 02/2013
6Carcinoma (Carcinomatosis)
10/2021 - 11/2016
5Melanoma (Melanoma, Malignant)
06/2023 - 01/2016
4Adenocarcinoma
11/2023 - 08/2018
3Neoplasm Metastasis (Metastasis)
01/2024 - 07/2021
2Pancreatic Neoplasms (Pancreatic Cancer)
10/2023 - 10/2022
2Microsatellite Instability
03/2021 - 10/2020
2Carcinogenesis
01/2020 - 10/2013
1Circulating Neoplastic Cells
01/2024
1Margins of Excision
11/2023
1Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer)
10/2020
1Endometrial Neoplasms (Endometrial Cancer)
10/2020
1Lung Neoplasms (Lung Cancer)
10/2019
1Disease Progression
05/2019
1Residual Neoplasm
01/2019
1Sarcoma (Soft Tissue Sarcoma)
11/2016
1Neuroblastoma
11/2016
1Anaphylaxis (Anaphylactic Shock)
09/2016
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
06/2016

Drug/Important Bio-Agent (IBA)

12DNA (Deoxyribonucleic Acid)IBA
10/2021 - 02/2013
11ParaffinIBA
10/2020 - 02/2013
10Formaldehyde (Formol)FDA Link
10/2020 - 03/2013
5Tumor Biomarkers (Tumor Markers)IBA
10/2022 - 03/2019
5Proteins (Proteins, Gene)FDA Link
01/2020 - 10/2013
4Cell-Free Nucleic AcidsIBA
01/2024 - 01/2020
4Monoclonal AntibodiesIBA
01/2019 - 03/2013
3Biomarkers (Surrogate Marker)IBA
10/2022 - 10/2013
3Circulating Tumor DNAIBA
10/2021 - 01/2018
2AntigensIBA
11/2023 - 10/2022
2GemcitabineFDA Link
11/2023 - 10/2022
2Estrogen ReceptorsIBA
10/2023 - 10/2013
2Phosphotransferases (Kinase)IBA
06/2023 - 10/2013
2ErbB Receptors (EGF Receptor)IBA
01/2019 - 03/2013
1Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2023
1Leucovorin (Folinic Acid)FDA Link
11/2023
1Irinotecan (Camptosar)FDA LinkGeneric
11/2023
1RNA (Ribonucleic Acid)IBA
11/2023
1Fluorouracil (Carac)FDA LinkGeneric
11/2023
1Poly(ADP-ribose) Polymerase InhibitorsIBA
10/2023
1olaparibIBA
10/2023
1RibonucleoproteinsIBA
10/2023
1Progesterone Receptors (Progesterone Receptor)IBA
10/2023
1Hormones (Hormone)IBA
10/2023
1MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA
06/2023
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
06/2023
1Carcinoembryonic AntigenIBA
10/2022
1Biological FactorsIBA
10/2022
1CarbohydratesIBA
10/2022
1Keratin-19 (Keratin 19)IBA
03/2022
1Nucleic AcidsIBA
03/2022
1Messenger RNA (mRNA)IBA
03/2022
1DNA-Binding Proteins (DNA Binding Protein)IBA
01/2022
1Viral DNAIBA
10/2021
1DecitabineFDA Link
05/2019
1MicroRNAs (MicroRNA)IBA
05/2019
1Protein Isoforms (Isoforms)IBA
05/2019
1Phenobarbital (Luminal)FDA Link
05/2019
1NFI Transcription FactorsIBA
12/2018
1epinephryl borate (Epinal)IBA
08/2018
1Proto-Oncogene Proteins c-metIBA
11/2016
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
11/2016
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
11/2016
1TensinsIBA
11/2016
1Trastuzumab (Herceptin)FDA Link
09/2016
1PhosphoproteinsIBA
09/2016
1Radioisotopes (Radionuclides)IBA
09/2016
1IsotopesIBA
09/2016
1Epidermal Growth Factor (EGF)IBA
09/2016
1Coloring Agents (Dyes)IBA
09/2016
1Sirolimus (Rapamycin)FDA Link
09/2016
1Mitogen-Activated Protein KinasesIBA
09/2016
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
09/2016
1Phosphatidylinositols (Phosphatidylinositol)IBA
09/2016
1Dasatinib (BMS 354825)FDA Link
06/2016
1Esomeprazole (Nexium)FDA Link
06/2016
1Growth Factor ReceptorsIBA
01/2016
1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
10/2013
1p38 Mitogen-Activated Protein KinasesIBA
10/2013

Therapy/Procedure

17Therapeutics
11/2023 - 02/2013
2Immunotherapy
06/2023 - 10/2020
2Drug Therapy (Chemotherapy)
01/2022 - 01/2016
2Precision Medicine
10/2020 - 10/2013
1Segmental Mastectomy (Lumpectomy)
09/2016